<h4>Background</h4><i>APOE</i> ε4/ε4 genotype increases the risk of Amyloid-Related Imaging Abnormalities (ARIA) from anti-amyloid antibody treatment (AAT). This evidence concerns the gene APOE and amyloidosis.